Media Summary: In this JCO Precision Oncology Article Insights episode, Miki Horiguchi summarizes two articles: “Biomarker-Driven Oncology Trial ... About this course: If you've ever skipped over`the results section of a This is Angela Preston talking about the value of the

Statistical Considerations In The Clinical - Detailed Analysis & Overview

In this JCO Precision Oncology Article Insights episode, Miki Horiguchi summarizes two articles: “Biomarker-Driven Oncology Trial ... About this course: If you've ever skipped over`the results section of a This is Angela Preston talking about the value of the Janet Wittes, Eric Leifer, Bill Abraham, and Mitchell Psotka join the podcast to discuss all-things Dr. Emily Morris, mathematical statistician at FDA's Center for Drug Evaluation and Research, discusses the unique This video is part of the HMP Education content archive and may include previously accredited educational material. While this ...

Photo Gallery

"Design and Statistical Considerations for Clinical Trials"
JCO PO Article Insights: Statistical Considerations for Biomarker-Driven Oncology Clinical Trials
Statistical considerations in the clinical development of novel cancer therapies
Understanding Clinical Research: Behind the Statistics MOOC
Statistical Considerations: Phase 1 & 2 Clinical Trials
CTTG Lecture 14 - Statistical Considerations in Clinical Trials with Dr. Robert Balshaw
Statistical Analysis Plans video
The role of statistics in clinical trials
Statistical Considerations for Phase II Clinical Trials and Adaptive Designs
Ep.3: Statistical Considerations in Heart Failure Research
FDA Grand Rounds - Statistical Considerations for Drug Development in Rare Disease
Keynote Lecture 6: Statistics for clinicians
View Detailed Profile
"Design and Statistical Considerations for Clinical Trials"

"Design and Statistical Considerations for Clinical Trials"

CRDEB January Symposium: WVCTSI

JCO PO Article Insights: Statistical Considerations for Biomarker-Driven Oncology Clinical Trials

JCO PO Article Insights: Statistical Considerations for Biomarker-Driven Oncology Clinical Trials

In this JCO Precision Oncology Article Insights episode, Miki Horiguchi summarizes two articles: “Biomarker-Driven Oncology Trial ...

Statistical considerations in the clinical development of novel cancer therapies

Statistical considerations in the clinical development of novel cancer therapies

... some uh

Understanding Clinical Research: Behind the Statistics MOOC

Understanding Clinical Research: Behind the Statistics MOOC

About this course: If you've ever skipped over`the results section of a

Statistical Considerations: Phase 1 & 2 Clinical Trials

Statistical Considerations: Phase 1 & 2 Clinical Trials

Part of the

CTTG Lecture 14 - Statistical Considerations in Clinical Trials with Dr. Robert Balshaw

CTTG Lecture 14 - Statistical Considerations in Clinical Trials with Dr. Robert Balshaw

Statistical Considerations

Statistical Analysis Plans video

Statistical Analysis Plans video

This is Angela Preston talking about the value of the

The role of statistics in clinical trials

The role of statistics in clinical trials

Julius Sim, statistician in the Keele

Statistical Considerations for Phase II Clinical Trials and Adaptive Designs

Statistical Considerations for Phase II Clinical Trials and Adaptive Designs

J. Jack Lee, PhD, DDS.

Ep.3: Statistical Considerations in Heart Failure Research

Ep.3: Statistical Considerations in Heart Failure Research

Janet Wittes, Eric Leifer, Bill Abraham, and Mitchell Psotka join the podcast to discuss all-things

FDA Grand Rounds - Statistical Considerations for Drug Development in Rare Disease

FDA Grand Rounds - Statistical Considerations for Drug Development in Rare Disease

Dr. Emily Morris, mathematical statistician at FDA's Center for Drug Evaluation and Research, discusses the unique

Keynote Lecture 6: Statistics for clinicians

Keynote Lecture 6: Statistics for clinicians

This video is part of the HMP Education content archive and may include previously accredited educational material. While this ...

Methodological and statistical considerations in implementation science

Methodological and statistical considerations in implementation science

Methodological and